title: Severe gouty arthritis refractory to anti-inflammatory drugs: treatment with anti-tumour necrosis factor alpha as a new therapeutic option.
authors.forename: A K
authors.initials: AK
authors.lastname: Tausche
authors.forename: K
authors.initials: K
authors.lastname: Richter
authors.forename: A
authors.initials: A
authors.lastname: Grässler
authors.forename: S
authors.initials: S
authors.lastname: Hänsel
authors.forename: B
authors.initials: B
authors.lastname: Roch
authors.forename: H E
authors.initials: HE
authors.lastname: Schröder
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D015210:Arthritis, Gouty / Q000188:drug therapy*; D000068800:Etanercept; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use*; D017211:Treatment Failure
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D018501:Antirheumatic Agents; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D000068800:Etanercept